Deborah J. Wexler, MD, MSc, is Associate Professor of Medicine at Harvard Medical School, Boston, Massachusetts, the Associate Clinical Chief of the MGH Diabetes Unit, and Clinical Director of the MGH Diabetes Center. She received her medical degree from Yale University School of Medicine, New Haven, Connecticut, her MSc from the University of Oxford, and completed her internship, residency, and chief residency in internal medicine and fellowship in endocrinology at Massachusetts General Hospital.

Dr. Wexler’s research focuses on clinical effectiveness in type 2 diabetes. She is the MGH site Principal Investigator and is on the Executive Committee of the GRADE Study, a NIH-funded multicenter trial to determine which second hypoglycemic drug, added to metformin, is most effective for patients with type 2 diabetes (http://gradestudy.com/). She is also multiple-Principal Investigator of the REAL HEALTH-Diabetes trial, which is translating the Look AHEAD lifestyle intervention for type 2 diabetes into usual care at community health centers. She served on the American Diabetes Association’s Professional Practice Committee (2014-2016) and was a co-author of the ADA-EASD position statement on management of hyperglycemia in type 2 diabetes. Dr Wexler is on the Editorial Board of Diabetes Care and is a reviewer for multiple medical journals.